<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recurrent <z:mp ids='MP_0000512'>intestinal ulcer</z:mp> is a frequent problem in the management of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="1" pm="."><plain>However, no standard therapy for intestinal Beheçt's disease has been established </plain></SENT>
<SENT sid="2" pm="."><plain>We report two patients with intestinal <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease and recurrent ileal <z:mpath ids='MPATH_579'>ulcers</z:mpath> who were treated successfuly with a <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient, the cecal <z:mpath ids='MPATH_579'>ulcer</z:mpath> did not relapse after the intravenous administration initiation of a <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> once a week, despite the discontinuation of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In the other patient, the cecal <z:mpath ids='MPATH_579'>ulcer</z:mpath> showed a healing tendency, and oral administration of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> was reduced from 40 to 15 mg/day after intravenous administration of a <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Both patients experienced no complications associated with the administration of the emulsion </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that an intravenous drug delivery system using a <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsion of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> is useful for treatment of intestinal <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>